Ildong Pharmaceutical Co., Ltd. (KRX:249420)

South Korea flag South Korea · Delayed Price · Currency is KRW
18,230
-1,470 (-7.46%)
Last updated: Jun 8, 2026, 1:38 PM KST
Market Cap620.71B +92.2%
Revenue (ttm)572.95B -4.5%
Net Income34.91B
EPS1,137.36
Shares Out 31.51M
PE Ratio17.32
Forward PEn/a
Dividend200.00 (1.02%)
Ex-Dividend DateMar 30, 2026
Volume134,003
Open17,600
Previous Close19,700
Day's Range17,600 - 18,990
52-Week Range11,910 - 45,050
Beta0.82
Analystsn/a
Price Targetn/a
Earnings DateMay 13, 2026

About Ildong Pharmaceutical

Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-cancer, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, and urogenital system applications. It also provide... [Read more]

Sector Healthcare
Founded 1941
Employees 1,061
Stock Exchange Korea Stock Exchange
Ticker Symbol 249420
Full Company Profile

Financial Performance

Financial Statements